Search for Clinical Trial Results
Immunoblastic Lymphadenopathy - 269 Studies Found
Status | Study |
Recruiting |
Study Name: A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma Condition: Lymphoma Date: 2017-01-16 Interventions: Drug: plitidepsin Other Name: APLD Aplidine |
Recruiting |
Study Name: Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL) Condition: T-cell Lymphoma Date: 2012-01-20 Interventions: Drug: Lenalidomide Lenalidomide |
Recruiting |
Study Name: Risk Stratification of Nodal PTCL Condition:
|
Recruiting |
Study Name: Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP Condition:
|
Recruiting |
Study Name: CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study Condition:
|
Recruiting |
Study Name: Romidepsin in Combination With CHOEP as First Line Treatment Before Hematopoietic Stem Cell Transplantation in Young Patients With Nodal Peripheral T-cell Lymphomas: a Phase I-II Study Condition:
|
Recruiting |
Study Name: Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma Condition:
|
Completed |
Study Name: RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas Condition:
Interventions: Drug: RAD001 (Everolimus) Phase I Level 1: RAD001 2.5 mg PO daily D1-14 + CHOP Level 2: RAD001 5 mg PO d |
Active, not recruiting |
Study Name: Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma Condition:
Interventions: Drug: carfilzomib Given IV Other Names: |
Recruiting |
Study Name: Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma Condition:
|